UFF
BIIB icon

USA FINANCIAL FORMULAS’s Biogen BIIB Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767K Buy
+3,548
New +$679K 0.14% 50

Other funds holding BIIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

USA FINANCIAL FORMULAS's BIIB Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Biogen (BIIB) in Q2 2026: 3,548 shares worth $767K. The stake represents 0.14% of the portfolio and ranks #50 among its holdings.

459 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • USA FINANCIAL FORMULAS held 3,548 shares of Biogen worth $767K as of Q2 2026.
  • Biogen was a new USA FINANCIAL FORMULAS position in Q2 2026.
  • Biogen made up 0.14% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #50 holding.
  • 459 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.